Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Revised breast implant settlement agreed

This article was originally published in Clinica

Executive Summary

Inamed's McGhan subsidiary and Union Carbide have joined Bristol-Myers Squibb, Baxter and 3M in the revised settlement for breast implant litigation (see Clinica No 675, p 5). The new offer, agreed last week, provides compensation from $10,000 to $250,000 for present and future claimants. The deal covers fewer than half the 440,000 women who joined the global settlement. Bristol-Myers Squibb estimates that about 50,000 women with current illnesses and 140,000 who have registered for future claims will be covered by the deal.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094136

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel